Voit & Company’s AbbVie ABBV Stock Holding History

Voit & Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$4.42M	Buy	50,437 +503	+1%	+$47.4K	4.27%	10
2020 Q2	$4.9M	Sell	49,934 -4,529	-8%	-$399K	5.22%	4
2020 Q1	$4.15M	Buy	54,463 +7,401	+16%	+$630K	4.28%	6
2019 Q4	$4.17M	Buy	47,062 +1,840	+4%	+$153K	3.71%	8
2019 Q3	$3.42M	Sell	45,222 -2,538	-5%	-$174K	3.39%	9
2019 Q2	$3.47M	Sell	47,760 -1,520	-3%	-$119K	3.32%	10
2019 Q1	$3.97M	Sell	49,280 -1,390	-3%	-$114K	4.18%	5
2018 Q4	$4.67M	Buy	+50,670	New	+$4.46M	5.87%	1

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Voit & Company's ABBV Position: Q3 2020 in Review

Voit & Company increased its AbbVie (ABBV) stake by 1% in Q3 2020, buying an estimated $47.4K and bringing the position to 50,437 shares worth $4.42M. The position accounts for 4.27% of the portfolio, ranked #10.

Voit & Company first reported a position in ABBV in Q4 2018 and has held it in 8 quarters since. The position peaked at $4.9M in Q2 2020. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

Voit & Company held 50,437 shares of AbbVie worth $4.42M as of Q3 2020.
Voit & Company bought 503 AbbVie shares in Q3 2020, an estimated $47.4K.
AbbVie made up 4.27% of Voit & Company's portfolio in Q3 2020, its #10 holding.
Voit & Company first reported a position in AbbVie in Q4 2018 and has held it in 8 quarters since.
Voit & Company's AbbVie position peaked at $4.9M in Q2 2020.
2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Voit & Company's 13F filing for Q3 2020, filed 30 Oct 2020.